Maximus (NYSE:MMS) Stock Price Down 4.5% – Time to Sell?

Maximus, Inc. (NYSE:MMS) shares dropped 4.5% on Tuesday . The company traded as low as $71.81 and last traded at $73.7640. Approximately 116,833 shares changed hands during trading, a decline of 84% from the average daily volume of 710,656 shares. The stock had previously closed at $77.28.

Analyst Ratings Changes

MMS has been the subject of several research analyst reports. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Maximus presently has a consensus rating of “Buy”.

Maximus Stock Down 4.9%

The company has a market cap of $4.01 billion, a P/E ratio of 11.18 and a beta of 0.59. The company’s 50-day moving average is $85.58 and its two-hundred day moving average is $86.06. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period last year, the business posted $1.61 EPS. The company’s revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were paid a $0.33 dividend. This is a boost from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, February 13th. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Insider Activity at Maximus

In related news, CFO David Mutryn acquired 1,000 shares of the stock in a transaction that occurred on Monday, February 9th. The shares were bought at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer directly owned 40,037 shares in the company, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bruce Caswell bought 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the acquisition, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. The trade was a 0.98% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Royal Bank of Canada lifted its stake in shares of Maximus by 146.2% in the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after purchasing an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares during the period. Jane Street Group LLC raised its position in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after acquiring an additional 88,835 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in shares of Maximus during the 2nd quarter worth $204,000. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.